Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Ind-Swift Laboratories Ltd, Fischer Medical Ventures Ltd, Robust Hotels Ltd and Bang Overseas Ltd are among the other losers in the BSE's 'B' group today, 10 July 2025.
Eimco Elecon (India) Ltd tumbled 9.87% to Rs 2481.1 at 14:31 IST.The stock was the biggest loser in the BSE's 'B' group.On the BSE, 6360 shares were traded on the counter so far as against the average daily volumes of 1267 shares in the past one month.
Ind-Swift Laboratories Ltd lost 8.70% to Rs 106.45. The stock was the second biggest loser in 'B' group.On the BSE, 59727 shares were traded on the counter so far as against the average daily volumes of 36598 shares in the past one month.
Fischer Medical Ventures Ltd crashed 7.25% to Rs 779. The stock was the third biggest loser in 'B' group.On the BSE, 4673 shares were traded on the counter so far as against the average daily volumes of 14659 shares in the past one month.
Robust Hotels Ltd corrected 6.10% to Rs 281.8. The stock was the fourth biggest loser in 'B' group.On the BSE, 11348 shares were traded on the counter so far as against the average daily volumes of 1167 shares in the past one month.
Bang Overseas Ltd plummeted 5.58% to Rs 58.07. The stock was the fifth biggest loser in 'B' group.On the BSE, 2606 shares were traded on the counter so far as against the average daily volumes of 6689 shares in the past one month.
Fischer Medical Ventures (FMV) announced the successful acquisition of a landmark mixed-use property in Malacca, Malaysia. Strategically located next to the renowned Mahkota Hospital, the property comprises hotel, commercial, and retail components, and will serve as the foundation for FMV's regional healthcare hub.
This acquisition represents a key milestone in FMV's strategic growth plan to expand its presence across the healthcare value chain. FMV intends to progressively redevelop portions of the property into integrated healthcare facilities, including health screening centers, specialist clinics, and medical suites. The development will also serve as a direct channel to showcase and distribute FMV's advanced medical device solutions to healthcare providers and patients.
For the full year,net profit declined 20.11% to Rs 1.47 crore in the year ended March 2025 as against Rs 1.84 crore during the previous year ended March 2024. Sales rose 427.65% to Rs 110.70 crore in the year ended March 2025 as against Rs 20.98 crore during the previous year ended March 2024.